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Abstract
Involvement of the central nervous system by multiple
myeloma (MM) is considered to be extremely rare. Magnetic
Resonauce Imaging (MRI) is the imaging modality of choice
to detect and differentiate myeloma at unusual sites. We
present the case of a sixty year old man who was a known case
of MM. In this case report MRI findings of central nervous
system in myeloma lesions are reported. The purpose is to
increase the awareness of the clinical presentation, neuro-
radiological findings and follow-up of multiple myeloma with
intracranial growth. There are only a few reported cases found
concerning MM with intracranial involvement in the
literature. To the best of our knowledge, there is no such
published literature available locally.
Introduction
Multiple myeloma is a disease characterized by
proliferation of malignant plasma cells and a subsequent
overabundance of monoclonal paraprotein.1 Multiple
myeloma (MM) accounts for 1% of all malignant diseases
and represents about 10% of all haematological
malignancies.2Male to female ratio is 1.4:1. The majority of
patients are older than 65 years.3 The cause of multiple
myeloma is unknown2. The predominant sites of
involvement are vertebral column, ribs, skull, pelvis and
femora. Extra osseous myeloma deposits are occasionally
found, in the lungs, nasopharynx or paranasal sinuses.3Most
common clinical features of MM are osteolytic lesions,
bleeding, anaemia, renal insufficiency, pathologic fractures,
spinal cord compression and recurrent bacterial infections.4
Intracranial structures are rarely involved by multiple
myeloma.5 The median interval from diagnosis of MM to the
documentation of CNS involvement is reported to be around
8.5 months.6 The most common presenting symptoms in case
of intracranial involvement include extremity weakness,
change of mental status, and cranial nerve palsies. The
prognosis is poor; with the median overall survival from the
time of diagnosis of CNS involvement is only 1.5 months.6
Case Report
A 60 years old male patient was admitted with
shortness of breath, altered mental status and drowsiness for
three days. His symptoms had started one year back. Detailed
work-up was done and he was diagnosed as Multiple
Myeloma IgM type with extensive bony involvement. He
underwent multiple sessions of plasmaphresis and was put on
chemotherapy.
MRI on readmission revealed multiple abnormal
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hyperintense T2 signal areas in the base of the skull and skull
vault. Abnormal signals were also identified in the left
cerebellar hemisphere showing diffusion restriction on
diffusion weighted images. Hyperintense signals were
identified in the region of the left posterior cerebral artery
territory which showed post contrast enhancement. Further
evidence of abnormal signals was seen within right ventricle
associated with its mild enlargement and post contrast
enhancement. Post contrast enhancement was also identified
at the left lateral ventricle, third and fourth ventricle and
suggestive of ependymal disease. However, no evidence of
pachymeningeal or leptomeningeal disease was present.
There was further evidence of two rounded, well defined
lesions, in frontal and parietal lobes adjacent to the right
lateral ventricle which appear to be heterogeneous on T2
weighted images with significant surrounding oedema
particularly in the region of frontal lobe. On post contrast
images the lesion in the frontal lobe showed ring
enhancement with some evidence of nodularity at its anterior
margin. The lesion in the parietal lobe showed only a small
central focus of enhancement. All these findings represented
metastatic deposits of the multiple myeloma. These appeared
to be in close proximity and a possible continuation of
abnormal signals in the ventricular system suggestive of
subarachnoid spread of the disease.
Patient died after two days of admission.
Discussion
Multiple Myeloma is a diffuse disease of the bone
marrow. Almost 90% of patients with myeloma have osseous
involvement. Although any bone can be affected,
predominant sites of involvement are vertebral column, ribs,
skull, pelvis and femora. Extraosseous myeloma deposits are
occasionally found, most commonly in the lungs,
nasopharynx or paranasal sinuses.3 Intracranial involvement
is rare, most frequently resulting from osseous lesions in the
cranial vault, skull base, and nose or paranasal sinuses.7
Patient usually presents with skeletal pain, osteolytic
lesions, bleeding, anaemia, renal insufficiency, pathologic
fractures, spinal cord compression and recurrent bacterial
infections.4 Intracranial extension of the tumour may give rise
to papilloedema, extremity weakness, change of mental
status, and cranial nerve palsies.6
Four distinct radiographic patterns of involvement are
seen, including the solitary lesion (plasmacytoma), diffuse
skeletal involvement (myelomatosis), diffuse skeletal
osteopenia and sclerosing myeloma.8
Imaging studies in the workup of patients with MM
include radiographic skeletal surveys, CT, Nuclear medicine
bone scanning. MR imaging of bone marrow has allowed a
direct look at the actual tumour burden within the bone
marrow. More recently positron emission tomography (PET)
with fluorodeoxyglucose (FDG) has been used.2
Skeletal radiography continues to be the primary
diagnostic study to aid in the detection of destructive bone
changes in MM. Estimates suggests that approximately 50%
of bone destruction must occur before there is radiographic
demonstration of the abnormality and that 75% of patients
with MM have positive radiographic findings.2
MR imaging findings in MM closely reflect the broad
spectrum of pathologic tumour spread. This modality can be
used to determine the exact location, size and local
compressive effects of the disease and possible associated
fractures. MRI imaging of brain is performed to examine
diploic involvement of the calvarium and skull base. It is
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Figure-1: (a) T1-Weighted axial image: Two rounded, well defined hypointense
lesions are seen in the right frontal and parietal regions adjacent to the ventricle
with extensive surrounding edema. (b) T2-Weighted axial image: Two rounded,
well defined heterogeneous signal intensity lesions are seen in right frontal and
parietal regions. There are also abnormal signals within the body of right lateral
ventricle causing its slight enlargement. (c) T2-Weighted axial image: Note
hyperintense signal areas in the base of skull. There is small hyperintense signal
area in left cerebellar hemisphere which demonstrated diffusion restriction. (d) T2-
Weighted axial image showing multiple well defined hyperintense signal intensity
areas of varying sizes in the skull vault. (e) Diffusion weighted axial MR image
showing diffusion restriction in left cerebellar lesion.
Figure-2: (a) Post contrast Axial image: Frontal lobe lesion shows ring
enhancement and parietal lobe lesion showing a small central focus of
enhancement. There is also enhancement of the ependymal lining of right lateral
ventricle. (b) Post contrast sagittal image: Frontal lobe lesion showing ring
enhancement with nodularity at its antero- superior margin. (c) Post contrast axial
image shows enlargement of right lateral ventricle with enhancement seen at the
margins of ventricles.
also helpful in precisely defining radiation therapy ports.
Post treatment MR images helps in defining response to
treatment. An additional use of MR imaging is the
delineation of the effect and complications of the highly
involved therapeutic protocols.2
Multiple sequences have been proposed for use in
identifying focal or diffuse disease. These include spin echo
(T1-Weighted and T2-Weighted), Gradient echo (T2*
Weighted), STIR (Short T1 inversion recovery), and contrast
material-enhanced spin echo (with and without fat
suppression) sequences.9 Intracranial involvement is rare,
primary dural or leptomeningeal involvement is rarer.7 It is
most frequently the result of contiguous spread from osseous
lesions. Infiltration of the duramater is likely to have been
caused by spread from contiguous bone lesions, whereas
involvement of the leptomeninges probably occurs by the
haematogenous route. Leptomeningeal involvement is
associated with a very poor prognosis; however, patients with
dural involvement show a more favourable response to
combined chemoradiotherapy.10 In our case lesions were seen
in skull vault as well as adjacent frontal lobe. There was also
involvement of the ependymal lining of the ventricles.
The neuroradiological findings are no different from
meningioma, metastasis, lymphoma, dural sarcoma, plasma
cell granuloma, infectious meningitis and leptomeningeal
carcinomatosis. Intracranial involvement from multiple
myeloma must be taken into account in the differential
diagnosis of cranial osseous and meningeal diseases.7
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